Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light–Dark Test in Mice

Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light–Dark Test in Mice

Earlier studies have shown that combination of antibodies to S100 protein and to cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic properties and decrease nicotine dependence. Released-active form of antibodies is a novel approach that permits to modify natural f...

Full description

Bibliographic Details
Main Authors: Elena V. Kardash, Irina A. Ertuzun, Gul'nara R. Khakimova, Andrey N. Kolyadin, Sergey A. Tarasov, Stéphanie Wagner, Emile Andriambeloson, Vladimir T. Ivashkin, Oleg I. Epstein
Format: Article
Language:English
Published: SAGE Publishing 2018-06-01
Series:Dose-Response
Online Access:https://doi.org/10.1177/1559325818779752

Internet

https://doi.org/10.1177/1559325818779752

Similar Items